Foundayo vs Zepbound: Pill vs Injection, Same Company
Foundayo and Zepbound are both Eli Lilly products, but they serve different purposes in your weight loss journey. Lilly has explicitly positioned them as complementary: 'Use Zepbound to lose, switch to Foundayo to maintain.' But is that the right strategy for everyone? Let's compare.
Weight Loss: Zepbound Is the Heavy Hitter
Zepbound wins on raw efficacy — by a wide margin. In SURMOUNT-1, tirzepatide at the 15mg dose showed approximately 22.5% body weight loss over 72 weeks. That's nearly double Foundayo's 12.4%.
The difference is pharmacological: Zepbound is a dual GIP/GLP-1 full agonist, stimulating two incretin pathways. Foundayo is a GLP-1-only partial agonist, with lower-intensity stimulation of one pathway.
This matters for timing: If you're in the active weight loss phase and need maximum help, Zepbound is the more powerful tool. If you've already reached your goal weight and want to maintain it affordably, Foundayo makes more sense.
Lilly's Two-Drug Strategy
Lilly explicitly positions these as a two-phase approach:
- Phase 1 — Lose: Use Zepbound (tirzepatide) for aggressive weight loss
- Phase 2 — Maintain: Switch to Foundayo (orforglipron) for long-term maintenance
This strategy makes clinical and financial sense. You get maximum weight loss from the most effective drug, then step down to a cheaper, more convenient oral option for the long term. Lilly benefits because they keep you in their ecosystem.
But it's not for everyone. If your insurance covers one but not the other, or if you prefer to start with the simplest option, you might skip Zepbound entirely and go straight to Foundayo.
Cost Comparison
Both are Lilly products, but pricing differs significantly:
- Foundayo: $149/month (starting) to $349/month (highest dose) self-pay via LillyDirect
- Zepbound: $1,086/month list price. LillyDirect self-pay starts at $299/month (2.5mg) and goes up for higher doses. Savings card: $25/month for eligible insured patients.
For patients without insurance coverage, Foundayo at $149-349/month is dramatically more affordable than Zepbound at full price.
Side Effects
Both cause similar types of GI side effects, but Foundayo's rates are slightly lower:
- Nausea: Foundayo ~25% vs Zepbound ~28%
- Diarrhea: Foundayo ~18% vs Zepbound ~23%
- Constipation: Foundayo ~14% vs Zepbound ~11%
The side effect profiles are generally similar. Zepbound has injection site reactions (~3.2%) that Foundayo eliminates entirely.
Compare Your Personalized Switch Plan
Frequently Asked Questions
Sources
- ATTAIN-1 Phase 3 Trial — orforglipron data
- SURMOUNT-1 Phase 3 Trial — tirzepatide weight loss data
- Foundayo (orforglipron) FDA Prescribing Information
- Zepbound (tirzepatide) FDA Prescribing Information
- Eli Lilly commercial strategy presentations, 2025-2026
Stay Updated
Get notified when Foundayo pricing changes, new GLP-1 options become available, or new switching data is published.
No spam. Unsubscribe anytime. We never share your email.
Ready to Make the Switch?
Talk to a doctor about switching to your new medication. These telehealth providers offer online consultations and GLP-1 prescriptions.
MedSwitcher may earn a commission from some providers. This does not affect our recommendations. Our switch plans are based on clinical data, not partnerships.